UPDATE: JPMorgan Downgrades Novavax (NVAX) to Underweight

September 22, 2022 3:04 AM EDT Send to a Friend
(Updated - September 22, 2022 4:17 AM EDT)

JPMorgan analyst Eric Joseph downgraded Novavax (NASDAQ: NVAX) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login